BioCryst Pharmaceuticals (BCRX) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

BioCryst Pharmaceuticals (BCRX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (04:14)

Sector: Healthcare

The share price of BioCryst Pharmaceuticals, Inc. (BCRX) now

Latest session on the 21st of June for
BioCryst Pharmaceuticals, Inc. is positive
Trading Volume: 15477239
Open: 6.18 /  High: 6.55 /  Low: 6.18
What analysts predict: $14
52-week High/Low: $7.95 / $4.03

50/200 Day Moving Average: $5.55 / $5.77

This figure corresponds to the Average Price over the previous 50/200 days. For BioCryst Pharmaceuticals stocks, the 50-day moving average is the support level today.

For BioCryst Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in BioCryst Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioCryst Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one BioCryst Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in BioCryst Pharmaceuticals stock? When should I record a loss on BioCryst Pharmaceuticals stock? What are analysts' forecasts for BioCryst Pharmaceuticals stock? What is the future of BioCryst Pharmaceuticals stock? We forecast BioCryst Pharmaceuticals stock performance using neural networks based on historical data on BioCryst Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BioCryst Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioCryst Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of BioCryst Pharmaceuticals stock

The chart below shows the historical price of BioCryst Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioCryst Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

BioCryst Pharmaceuticals, Inc., a biotech company, is dedicated to the discovery of oral and small molecule drugs. The company markets injections of peramivir, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza, under the names RAPIVAB, ALPIVAB, RAPIACTA and PERAMIFLU; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for the treatment of peripheral T-cell lymphoma.

BioCryst Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 6.40 6.26 6.47 3.28
Jun 26 6.38 6.25 6.47 3.58
Jun 27 6.37 6.31 6.47 2.61
Jun 28 6.23 6.14 6.28 2.25
Jun 29 6.14 6.03 6.28 4.28
Jun 30 6.22 6.14 6.28 2.31
Jul 01 6.17 6.11 6.30 3.06
Jul 02 6.21 6.16 6.31 2.30
Jul 03 6.26 6.19 6.31 1.82
Jul 04 6.33 6.22 6.46 3.78
Jul 05 6.28 6.22 6.36 2.30
Jul 06 6.37 6.27 6.43 2.59
Jul 07 6.31 6.22 6.41 2.98
Jul 08 6.37 6.26 6.41 2.47
Jul 09 6.42 6.30 6.56 4.22
Jul 10 6.51 6.46 6.66 2.99
Jul 11 6.43 6.37 6.52 2.33
Jul 12 6.42 6.34 6.56 3.40
Jul 13 6.39 6.29 6.51 3.50
Jul 14 6.24 6.11 6.32 3.34
Jul 15 6.30 6.22 6.42 3.34
Jul 16 6.13 6.08 6.22 2.42
Jul 17 6.28 6.15 6.38 3.80
Jul 18 6.32 6.21 6.36 2.51
Jul 19 6.49 6.41 6.63 3.47
Jul 20 6.55 6.43 6.60 2.66
Jul 21 6.36 6.21 6.46 4.09
Jul 22 6.34 6.19 6.49 4.76
Jul 23 6.37 6.26 6.48 3.51
Jul 24 6.18 6.09 6.25 2.68

BioCryst Pharmaceuticals Daily Price Targets


BioCryst Pharmaceuticals Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $6.40.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 3.174%.
Pessimistic target level: 6.26
Optimistic target level: 6.47

BioCryst Pharmaceuticals Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $6.38.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 3.458%.
Pessimistic target level: 6.25
Optimistic target level: 6.47

BioCryst Pharmaceuticals Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $6.37.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.540%.
Pessimistic target level: 6.31
Optimistic target level: 6.47

BioCryst Pharmaceuticals Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $6.23.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.202%.
Pessimistic target level: 6.14
Optimistic target level: 6.28

BioCryst Pharmaceuticals Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $6.14.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 4.106%.
Pessimistic target level: 6.03
Optimistic target level: 6.28

BioCryst Pharmaceuticals Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $6.22.
Positive dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.256%.
Pessimistic target level: 6.14
Optimistic target level: 6.28

BCRX (BCRX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 6.93 6.61 7.31 9.55
Aug. 6.90 6.72 7.09 5.14
Sep. 7.00 6.57 7.31 10.01
Oct. 7.41 6.83 7.92 13.82
Nov. 6.96 6.47 7.46 13.32
Dec. 6.72 6.29 7.14 11.86

BioCryst Pharmaceuticals forecast for this year


BioCryst Pharmaceuticals Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $6.92846. Pessimistic: $6.61. Optimistic: $7.31


BioCryst Pharmaceuticals Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $6.89521. Pessimistic: $6.72. Optimistic: $7.09


BioCryst Pharmaceuticals Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $7.00277. Pessimistic: $6.57. Optimistic: $7.31


BioCryst Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $7.41454. Pessimistic: $6.83. Optimistic: $7.92


BioCryst Pharmaceuticals Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $6.96077. Pessimistic: $6.47. Optimistic: $7.46


BioCryst Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $6.71853. Pessimistic: $6.29. Optimistic: $7.14



BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 6.32 5.84 6.83 14.53
Feb 6.08 5.65 6.34 10.93
Mar 6.09 5.81 6.53 10.97
Apr 6.02 5.78 6.20 6.87
May 5.94 5.64 6.08 7.27
Jun 6.25 6.04 6.45 6.39
Jul 6.02 5.81 6.23 6.83
Aug 6.28 5.99 6.67 10.18
Sep 6.89 6.45 7.07 8.78
Oct 7.37 6.97 8.03 13.23
Nov 6.94 6.29 7.56 16.75
Dec 7.51 6.87 7.70 10.77

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 8.13 7.45 8.68 14.26
Feb 7.57 6.90 8.15 15.38
Mar 6.66 6.34 6.88 7.79
Apr 6.89 6.24 7.14 12.61
May 6.18 5.84 6.47 9.73
Jun 5.94 5.77 6.12 5.82
Jul 6.03 5.53 6.24 11.48
Aug 5.87 5.57 6.20 10.12
Sep 5.71 5.49 5.98 8.14
Oct 5.29 5.07 5.51 8.05
Nov 5.41 5.04 5.87 14.25
Dec 4.84 4.46 5.06 11.82

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 4.50 4.13 4.77 13.49
Feb 4.50 4.32 4.93 12.50
Mar 4.90 4.58 5.25 12.79
Apr 4.67 4.43 4.89 9.50
May 4.94 4.76 5.34 10.88
Jun 5.12 4.86 5.53 12.09
Jul 4.91 4.79 5.24 8.65
Aug 4.85 4.72 4.99 5.48
Sep 5.07 4.80 5.31 9.63
Oct 5.26 4.78 5.48 12.78
Nov 5.46 5.03 5.82 13.51
Dec 5.28 5.05 5.53 8.59

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 5.49 5.35 5.76 6.98
Feb 5.79 5.63 5.95 5.37
Mar 5.52 5.21 5.74 9.24
Apr 5.94 5.40 6.21 12.98
May 5.68 5.31 5.94 10.66
Jun 5.58 5.24 6.04 13.28
Jul 6.05 5.75 6.62 13.17
Aug 6.53 6.37 6.92 7.92
Sep 6.83 6.46 7.43 13.02
Oct 6.57 6.34 6.90 8.11
Nov 6.59 6.20 6.94 10.60
Dec 6.29 6.03 6.85 11.90

BioCryst Pharmaceuticals information and performance

BioCryst Pharmaceuticals Address

4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, US

Market Capitalization: 1 324 940 000 $

Market capitalization of the BioCryst Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BCRX shares in the company outstanding by the market price of one share.

EBITDA: -82 086 000 $

EBITDA of BioCryst Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.28

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.07

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.349
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.283

Enterprise Value (EV) /Revenue

EV To EBITDA: -12.2

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 206377000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.